FcγR-driven chimeric receptor T cells in cancer therapy: a novel frontier in antibody-guided immunotherapy

Hany E Marei, Giacomo Pozzoli, Sara Caratelli, Carlo Cenciarelli · 2026

Read FcγR-driven chimeric receptor T cells in cancer therapy: a novel frontier in antibody-guided immunotherapy by Hany E Marei, Giacomo Pozzoli, Sara Caratelli, Carlo Cenciarelli (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13091257.txt.

Description

Hany Marei and co-authors review a new kind of engineered T cell for cancer in a 2026 paper. Standard CAR T cells carry a crafted sensor that locks onto one tumor target, and they shine in blood cancers but stall in solid tumors. The reviewed design swaps the sensor for parts of antibody receptors, so any tumor-targeting antibody can steer the cells.

That swap brings flexibility: one cell product can pair with many antibodies, and stopping the antibody can switch the cells off. The review covers how the cells work, lab results so far, and tuning ideas like sharpening the receptors or building off-the-shelf versions. Combining them with checkpoint drugs may crack resistant solid tumors. Hurdles of safety and precision remain.

Catalog record

CREATORHany E Marei, Giacomo Pozzoli, Sara Caratelli, Carlo Cenciarelli
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE109 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13091257

Browse the full library · About the Tower of Babel